ImmunoSep retweeted
Dr. Evangelos Giamarellos-Bourboulis giving us the update on the recently completed @immunosep trial… results expected fall 2024- comparing immunotherapy (MALS: anakinra or Immunoparalysis: interferon-gamma) vs std of care in patients with sepsis. A huge accomplishment!
ImmunoSep retweeted
If you are a hospital-based physician or a physician in training in the EU, please take this survey to help @immunosep investigators learn more about your impressions of immunotherapy for sepsis patients. Https://edu.nl/kh3c9
ImmunoSep retweeted
Excited to be in Greece this week with research collaborators to discuss Immunotherapy of Infectious Diseases, with 3 major trials in Sepsis @Immunosep, HAP, and Candidemia with @HdmFun supported by @HorizonEU.
🤝The ImmunoSep consortium is gathering for their final meeting in Kalamata to discuss the last steps to successfully conclude our project in the upcoming months. We're thrilled to have dedicated time for internal discussion points ahead of tomorrow's Symposium!
Register now for the International Symposium on #Immunotherapy of Severe Infections!
Join a broad diversity of scientists in the field of Immunotherapy as they convene from 16 to 17 May in Kalamata, Greece. #sepsis
👉 lnkd.in/eC4bX6Ef
After reaching the essential target of recruiting 280 patients with #sepsis for the #ImmunoSep clinical trial, partners are looking forward to jointly analyse the data over the next months. Meanwhile, read about challenges and achievements of the trial: tinyurl.com/y5xnbucz
ImmunoSep retweeted
“Sepsis really can happen to anyone. Not just the healthiest people, but the best people too.”
On behalf of her whole family, Maria Campanini is sharing her sister Gina’s story and delivers three key messages about #sepsis.
Read or watch Gina’s story: sepsistrust.org/about/about-…
🤝 Meet the @ImmunoSep young researchers who bring their expertise and passion to developing a #precisionmedicine-based approach for #Immunotherapy as novel treatment for #Sepsis
👉 immunosep.eu/news-and-events…
#horizon2020 #horizoneurope
📅 Save the date! @immunosep announces the International Symposium "Immunotherapy of Severe Infections" from 16th - 17th of May 2024 in Kalamata, Greece. Mark it in your calendars!
👉 lnkd.in/dJDgY_Rc
Stay tuned for more registration info!
@horizonEU #sepsis #infection
📢Just published! Prof. Evangelos Giamarellos-Bourboulis outlines the urgent need for breakthroughs in #sepsis diagnosis and treatment and introduces the @immunosep research... @hiss_eims @HorizonEU
👉immunosep.eu/news/horizon-ma…
📢200 patients are now enrolled in the @ImmunoSep clinical trial of Immunotherapy. Thanks to the teams working hard to reach the target of 280 patients: @hiss_eims, @CHUVLausanne, @uniklinik_jena, @amsterdamumc, #UMF!
👉Read more: immunosep.eu/news/milestone-…
ImmunoSep retweeted
📅 Today is #WorldSepsisDay!
Access and share our free resources to learn more about the critical role of diagnostics in #Sepsis management.
➡️ biomerieux.com/corp/en/educa…
Today and every day, let’s raise awareness on Sepsis!
#MedEd
Today is #WorldSepsisDay! 47 – 50 million people each year suffer from #Sepsis. Join us in highlighting the need for further research and #SepsisPrevention.
Join the Central Event for World Sepsis Day 2023 in Berlin tomorrow and listen to Prof. Evangelos J. Giamarellos Bourboulis of ImmunoSep partner @hiss_eims on the enactment of the WHO Sepsis resolution 👉
worldsepsisday.org/wsd-event…
ImmunoSep retweeted
Are you registered for the #SepsisAllianceSummit? This two-day virtual conference is set to take place next month – and it’s FREE to sign up!
Visit SepsisSummit.org to complete your registration, browse session topics, and learn about all of our expert speakers.
Together with all @ImmunoSep partners, the @Eurice_EU team ensures coherent external communication and maximises the impact of the project through dissemination and exploitation of results. Read more on immunosep.eu/partners/eurice @HorizonEU #sepsis
With its experience in supporting companies seeking to commercialise their technologies, @UniofReading focuses on supporting the future uptake of immunotherapy in #sepsis in ICU practice.
Read more on immunosep.eu/partners/uread @HorizonEU
With its competences in applied microbiology and infectious diseases, the @BIOASTER team participates in the analysis of the multi-omics characterisation of #sepsis patients.
Read more on immunosep.eu/partners/bioast… @HorizonEU
Being a leader in the field of in vitro diagnostics, the team @biomerieux participates in the analysis of of the multi-omics characterisation of #sepsis patients.
Read more on immunosep.eu/partners/bmx
@HorizonEU
























